372 related articles for article (PubMed ID: 6351988)
1. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
2. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Benson RC; Cummings K
Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
[No Abstract] [Full Text] [Related]
3. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
4. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
Németh A; Morvay J; Vécsei B
Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
[No Abstract] [Full Text] [Related]
5. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
Morales A; Nickel JC
Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
[TBL] [Abstract][Full Text] [Related]
6. The EORTC Phase III trials in prostatic cancer.
Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
[No Abstract] [Full Text] [Related]
7. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
Edsmyr F; Esposti PL; Andersson L
Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
9. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
[TBL] [Abstract][Full Text] [Related]
11. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
Flamm J; Fischer M
Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
13. Estramustine for prostate cancer.
Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
[No Abstract] [Full Text] [Related]
14. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
15. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026
[TBL] [Abstract][Full Text] [Related]
16. Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer.
Benson RC; Gill GM
Am J Clin Oncol; 1986 Aug; 9(4):341-51. PubMed ID: 3529921
[TBL] [Abstract][Full Text] [Related]
17. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
Mittelman A; Catane R; Murphy GP
Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
[TBL] [Abstract][Full Text] [Related]
18. Experience with estramustine phosphate.
Nilsson T; Wear JB
Wis Med J; 1976 Nov; 75(11):S121-S123. PubMed ID: 1007313
[No Abstract] [Full Text] [Related]
19. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
[No Abstract] [Full Text] [Related]
20. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
